BackNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Overview
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) P/E Ratio

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) has a P/E ratio of -10.64, below the sector sector average of 24.91.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-10.64

P/E Ratio

-10.64

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) FAQ

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) currently reports a P/E ratio of -10.64. That is below the sector sector average of 24.91. Use the charts on this page to explore NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s P/E ratio history and peer comparisons.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s P/E ratio of -10.64 is lower than the its sector sector average of 24.91. That is roughly 142.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s market price to a fundamental measure such as earnings, sales, or book value. At -10.64, NAMSW can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -10.64, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 24.91. From there, open related valuation or income-statement pages for NewAmsterdam Pharma Company NV - Warrants (15/11/2027), and consider following NAMSW for alerts when major investors trade the stock.